Exchange: OTC·Updated 03:05 PM EDT

FNCH Finch Therapeutics Group Inc

$10.35
$0.00
(0.00%)
Today
Reported EarningsMay 10
Mkt Cap$16.62M
Vol300.00

About FNCH

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
46

Neutral Sentiment

How do you feel about FNCH?

Advertisement|Remove ads.